Industry leading quality systems
and world-class regulatory expertise
ICH
The International Committee for Harmonisation (ICH)
This page provides access to regulatory guidance and other resources that are generally available from web sites operated and maintained by other organizations.
These guidelines have been prepared through close co-operation between the European Union, Japan and the United States of America.
Note: These links take you directly to the documents on the ICH or other authorities' web site. Please contact us and let us know if you have problems accessing them.
| Title |
|
Type |
Posted |
| |
Q7A; Good Manufacturing Practices for Active Pharmaceutical Ingredients.* |
Guidance for Industry |
November 2000 |
|
View PDF
|
| |
Q6B; Specifications, Test and procedures for Biotechnological/Biological Products* |
Note for Guidance |
January 1999 |
|
| |
S2B Genotoxicity: A Standard Battery for Genotoxicity Testing of |
Note for Guidance |
July 1997 |
View PDF
|
| |
E8; General Considerations for the clinical Trials |
Note for Guidance |
July 1997 |
View PDF
|
| |
S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals |
Note for Guidance |
July 1997 |
View PDF
|
| |
Q5A(R1): Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin |
Note for Guidance |
March 1997 |
View PDF
|
| |
Q5D; Derivation and Characterization of Cell substrates Used for Production of Biotechnological/Biological Products* |
Note for Guidance |
January 1997 |
|
| |
E6 Guidelines for Good Clinical Practice |
Note for Guidance |
April 1996 |
View PDF
|
| |
Q5C; Quality of Biotechnological Products: Stability Testing of Biotechnology/Biological Products |
Note for Guidance |
November 1995 |
View PDF
|
| |
Q5B: Quality of Biotechnological Products: Analysis of the Expression Construct in Cells Used for Production of r-DNA Derived Protein Products |
Note for Guidance |
November 1995 |
View PDF
|
IMPORTANT NOTICEThe links on this page are provided for the sole purpose of assisting visitors to locate the relevant web sites and BioReliance does not make any warranty with respect to the accuracy of the documents available from these sites. All documents are the copyright of the respective site owners and may be subject to certain conditions of use. Although care has been taken in the preparation of this web site BioReliance cannot be held responsible for the accuracy of the information contained within the web site, nor for any consequence arising from such information. You are advised to seek additional advice when making decisions based on information you have obtained from this web site.